Clinical data for control subjects and for patients with ulcerative colitis (UC), grouped by extent and activity of disease, at the start of the investigation
| Controls | UC, total, active | UC, total, inactive | UC, distal, active | |
|---|---|---|---|---|
| *Mean (range). | ||||
| Sex (F/M) | 7/4 | 4/6 | 3/7 | 2/6 |
| Age (y)* | 38.3 (23–72) | 30.7 (19–67) | 47 (22–68) | 38.0 (23–65) |
| Disease duration (y)* | 2.9 (0–9) | 15.7 (0–33) | 8.1 (1–35) | |
| Treatment (No of patients) | ||||
| Sulphasalazine | 2 | 2 | 1 | |
| Mesalazine | 3 | 3 | 4 | |
| Systemic steroids | 2 | 1 | 1 | |
| Azathioprine | 2 | 3 | 1 | |
| Topical steroids | 0 | 0 | 1 | |
| Topical mesalazine | 0 | 1 | 0 | |
| No treatment | 3 | 2 | 2 | |